Clinical trials: Cardiac Rhythm Disorders
Atrial Fibrillation, Mitral Valve Failure
Atrial Fibrillation Registry 2017
Monocentric, prospective, randomized trial of cardiac surgical arrhythmia using endocardial radiofrequency atrial ablation compared with a cryo ablation system in the setting of cardiac surgery.
- Trial name
- NCT05023590
- Testing
- ablation of left atrium during mitral valve open chest intervention
- Where
- Germany
- Volunteers
- 50 people
- Sponsor
- Herz- und Gefaesszentrum Bad Bevensen
Out-Of-Hospital Cardiac Arrest, Ventricular Fibrillation Sustained
Percutaneous Left Stellate Ganglion Block In Out-of-hospital Cardiac Arrest Due to Refractory VEntricular Arrhythmias (LIVE Study)
This is an observational, prospective study to verify the feasibility and practicability of percutaneous stellate ganglion block (PSGB) in patient suffering from a refractory out-of-hospital cardiac arrest (OHCA) due to a…
- Conditions
- Out-Of-Hospital Cardiac Arrest, Ventricular Fibrillation Sustained, Shockable Rhythm, Medical Etiology
- Trial name
- LIVE (NCT04168970)
- Testing
- PSGB
- Where
- 2 sites in Italy
- Volunteers
- 62 people
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
Atrial Fibrillation
Efficacy and Safety Study of F373280
The purpose of this study is to assess the efficacy of F373280 on the maintenance of normal cardiac rhythm after direct electric cardioversion in patients with persistent atrial fibrillation and cardiac failure.
- Trial name
- NCT01831856
- Testing
- 1g of F373280
- Where
- 20 sites in Czechia, Hungary and 3 more
- Volunteers
- 135 people
- Sponsor
- Pierre Fabre Medicament
Atrial Fibrillation (AF)
Accuracy of Cardiac Wearables Devices to Detect Atrial Fibrillation
Atrial fibrillation (AF) is the most common cardiac arrhythmia. This study is to assess the heart rhythm device accuracy of five cardiac wearable devices (Apple Watch, Kardia Mobile/Kardia Mobile 6L, Fitbit Sense, Samsung Galaxy…
- Trial name
- NCT04809922
- Testing
- cardiac wearable devices
- Where
- Switzerland
- Volunteers
- 312 people
- Sponsor
- University Hospital, Basel, Switzerland
Atrial Fibrillation, Heart Failure
Rate or Rhythm Control in CRT: the RHYTHMIC Study
70 patients with heart failure, AF and CRT with BiV<95% will be randomised to either AF ablation or AV node ablation. Evaluation at 6 months with echocardiography and clinical assessment.
- Trial name
- RHYTHMIC (NCT04664686)
- Testing
- AF catheter ablation, AV node ablation
- Where
- United Kingdom
- Volunteers
- 70 people
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
Atrial Fibrillation, Atrial Flutter
Validation of a Novel Smartphone-based Method for Heart Rhythm Monitoring in the Home Environment
Atrial fibrillation is a heart rhythm disorder with increased risk of stroke, heart failure, dementia and death. The severity of symptoms in atrial fibrillation varies markedly, ranging from no symptoms to those with disabling…
- Conditions
- Atrial Fibrillation, Atrial Flutter, Arrhythmia
- Trial name
- NCT04300270
- Testing
- Smartphone PPG recordings, Smartphone ECG
- Where
- Sweden
- Volunteers
- 480 people
- Sponsor
- Karolinska Institutet
Atrial Fibrillation (AF)
Testing the Performance of Smartphones and Their Accessories in Detecting Irregularly Irregular Heart Rhythm
The purpose of this 4-in-1 observational study is to test the performance of artificial intelligences (AIs) in distinguishing irregularly irregular heart rhythm called atrial fibrillation (AF) from normal heart rhythm using…
- Trial name
- NCT07154303
- Testing
- Computer algorithms
- Where
- China
- Volunteers
- 209 people
- Sponsor
- The University of Hong Kong
Breast Cancer
Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization)
The purpose of this study is to determine whether HKI-272 affects the rhythms of the heart (cardiac repolarization).
- Trial name
- NCT00708903
- Testing
- neratinib, Moxifloxacin
- Where
- United States
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Puma Biotechnology, Inc.
Persistent Atrial Fibrillation
Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation
A prospective, single-arm, multi-center, multi-national, non-randomized, post-market study designed to provide clinical data regarding the use of the AcQMap™ System in the ablation of persistent atrial fibrillation.
- Trial name
- UNCOVER-AF (NCT02825992)
- Testing
- AcQMap System
- Where
- 12 sites in Canada, Czechia and 4 more
- Volunteers
- 129 people
- Sponsor
- Acutus Medical
Murmur, Heart, Rhythm; Abnormal
Evaluation of Cardiags Trimod for Analysis of Cardiac Activity
The current study concerns Cardiags Trimod, a new non-invasive medical device for cardiac examinations. The evaluation of its effectiveness is done relative to specific standard devices.
- Trial name
- EVALTRIMOD (NCT05162599)
- Testing
- Diagnostic study, experimental evaluative cross-sectional study
- Where
- France
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- CARDIAGS
Atrial Fibrillation
RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) Episodes in the Cardiac Rhythm Management (CRM) Device Population
The purpose of this registry is to produce a prospective, outcome-oriented registry to document the prevalence of AT/AF in the CRM population by using the Advanced AT/AF Diagnostics in select SJM devices.
- Trial name
- RATE (NCT00837798)
- Testing
- CRM Device
- Where
- United States
- Volunteers
- 5,379 people
- Sponsor
- Abbott Medical Devices
Cardiovascular Diseases
Stroke Prevention and Rhythm Interventions in Atrial Fibrillation
This observational registry will characterize contemporary stroke prevention in Canadian adults with atrial fibrillation, and provide clarity in understanding physician preferences for the various oral anticoagulants available in…
- Trial name
- SPRINT-AF (NCT01733160)
- Where
- Canada
- Volunteers
- 2,499 people
- Sponsor
- Canadian Collaborative Research Network
Atrial Fibrillation
Effects of Fish Oil on Post Ablation Arrhythmias
To determine if peri-operative treatment with omega-3 fatty acids is associated with a decrease in the incidence of early recurrences of atrial arrhythmias (within 30 days) and an improvement in probability of long-term…
- Trial name
- NCT00791089
- Testing
- LOVAZA Omega 3-acid ethyl esters, LOVAZA
- Where
- United States
- Volunteers
- 12 people
- Sponsor
- University of Michigan